Oric Pharmaceuticals, Inc. (ORIC) vs Rapport Therapeutics, Inc. (RAPP)
- Oric Pharmaceuticals, Inc. ORIC 12.35 −3.29%
- Rapport Therapeutics, Inc. RAPP 27.57 −6.76%
Oric Pharmaceuticals, Inc. and Rapport Therapeutics, Inc. are both Biotechnology companies. Oric Pharmaceuticals, Inc. and Rapport Therapeutics, Inc. are of similar size ($1.4B and $1.3B). Across the 9 metrics below, Rapport Therapeutics, Inc. leads on 6 and Oric Pharmaceuticals, Inc. on 3.
Valuation
Profitability
| Metric | ORIC | RAPP | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | — | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (39.80%) | (39.96%) | (56.36%) |
| Return on assets | (37.35%) | (36.85%) | (48.04%) |
| Return on invested capital | (83.77%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack